Dr. Yeku is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114Phone+1 617-219-1230
Summary
- Dr. Oladapo Yeku is an oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Newton-Wellesley Hospital. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 8 years. He specializes in gynecologic cancer and is experienced in vulvar carcinoma and ovarian cancer. He has more than 30 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2018
UPMC Medical EducationResidency, Internal Medicine, 2012 - 2014
Stony Brook University Health Sciences Center School of MedicineClass of 2012
Medgar Evers CollegeBS, Biology, Summa Cum Laude, 2001 - 2005
Certifications & Licensure
MA State Medical License 2018 - 2025
NY State Medical License 2014 - 2025
PA State Medical License 2012 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma Start of enrollment: 2018 Aug 27
- A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) Start of enrollment: 2020 Jan 02
- PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer Start of enrollment: 2020 Aug 11
Publications & Presentations
PubMed
- 161 citationsLosartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stromaYanxia Zhao, Jinghong Cao, Alexander Melamed, Michael J. Worley, Allison Gockley
Proceedings of the National Academy of Sciences of the United States of America. 2019-01-18 - 515 citationsTargeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivoSarwish Rafiq, Oladapo Yeku, Hollie J. Jackson, Terence J. Purdon, Dayenne G. van Leeuwen
Nature Biotechnology. 2018-08-13 - 152 citationsArmored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacyOladapo Yeku, Renier J. Brentjens
Biochemical Society Transactions. 2016-04-15
Grant Support
- Facilitated Insulin Secretion VIA Ablation Of A Compartmentalized Pool Of PIP2National Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
